ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

LIXTW Lixte Biotechnology Holdings Inc

0.07
0.00 (0.00%)
20 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Lixte Biotechnology Holdings Inc LIXTW NASDAQ Warrant Capital Accionario
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.07 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.07 0.07
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202413:47EDGAR2Form 8-K - Current report
14/6/202410:00GLOBELIXTE Biotechnology Holdings announces collaboration on a..
14/6/202408:30GLOBELIXTE Biotechnology Holdings to Collaborate with Roche and..
14/6/202407:30EDGAR2Form 8-K - Current report
06/6/202407:30GLOBEScientific Journal Reports Findings that Show LIXTE’s Lead..
05/6/202414:55EDGAR2Form 8-K - Current report
03/6/202407:30GLOBELIXTE Biotechnology Holdings Names Distinguished Oncologist..
29/5/202416:29EDGAR2Form 8-K - Current report
20/5/202416:05EDGAR2Form 8-K - Current report
09/5/202411:00EDGAR2Form 8-K - Current report
09/5/202407:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202408:25GLOBELIXTE Biotechnology Co-Sponsoring International Scientific..
24/4/202414:25APSMixed Shelf Filing Gives Micro Cap Delayed Boost
27/3/202414:35APSBiotech Steals The Show Following Pre-Clinical Data..
27/3/202407:30GLOBENEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD..
21/3/202407:30GLOBELIXTE Provides Update on Progress with LB-100 as a PP2A..
27/2/202407:30GLOBEProfessor René Bernards to Present New Pre-Clinical Data on..
26/2/202407:30GLOBELIXTE Biotechnology Enters into Exclusive Immune Oncology..
29/1/202407:30GLOBEFirst Patient Dosed with LIXTE’s LB-100 and GSK’s..
13/11/202307:30GLOBELIXTE Biotechnology Provides Update on Clinical Progress and..
16/10/202307:30GLOBELIXTE, Netherlands Cancer Institute, and Oncode Institute to..
09/10/202307:30GLOBELIXTE Biotechnology Holdings Announces the Passing of its..
26/9/202307:30GLOBELIXTE Appoints Bas van der Baan as President and Chief..
20/9/202307:30GLOBELIXTE Biotechnology Announces a Supported Collaborative..
20/7/202315:05GLOBELIXTE Biotechnology Announces Closing of $3.5 Million..
18/7/202307:00GLOBELIXTE Biotechnology Announces Pricing of $3.5 Million..
17/7/202307:30GLOBEPreclinical Results of LIXTE Biotechnology’s Collaboration..